<div class="embed-responsive embed-responsive-16by9"><iframe width="640" height="360" style="max-width: 100%;max-height: 100%; border:none;" src="https://oncologytube.com/videoEmbed/28761/data-on-umbralisib-in-relapsed-refractory-lymphoma?channelName=obr&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" frameborder="0" allowfullscreen="allowfullscreen" allow="autoplay" scrolling="no">iFrame is not supported!</iframe></div>

Data on Umbralisib in Relapsed/Refractory Lymphoma

Name: Data on Umbralisib in Relapsed/Refractory Lymphoma
Uploaded: 2019-06-27T09:39:43
Duration: 1 min 44 s
Description: Lori A. Leslie, MD, Hematologist-Oncologist, Lymphoma Department, John Theurer Cancer Center, Hackensack Meridian Health explains the results of the umbralisib phase II study involving patients with relapsed/refractory lymphoma.

$Data on Umbralisib in Relapsed/Refractory Lymphoma$

00:01:44

Don

3 έτη 49 Προβολές

Μοιραστείτε το Προσθήκη Report 0 0

Ενσωμάτωση (Iframe):

<div class="embed-responsive embed-responsive-16by9"><iframe width="640" height="360" style="max-width: 100%;max-height: 100%; border:none;" src="https://oncologytube.com/videoEmbed/28761/data-on-umbralisib-in-relapsed-refractory-lymphoma?channelName=obr&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" frameborder="0" allowfullscreen="allowfullscreen" allow="autoplay" scrolling="no">iFrame is not supported!</iframe></div>

Ενσωμάτωση (Object):

<div class="embed-responsive embed-responsive-16by9"><object width="640" height="360"><param name="movie" value="https://oncologytube.com/videoEmbed/28761/data-on-umbralisib-in-relapsed-refractory-lymphoma?channelName=obr&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit="></param><param name="allowFullScreen" value="true"></param><param name="allowscriptaccess" value="always"></param><embed src="https://oncologytube.com/videoEmbed/28761/data-on-umbralisib-in-relapsed-refractory-lymphoma?channelName=obr&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" allowscriptaccess="always" allowfullscreen="true" width="640" height="360"></embed></object></div>

Link (HTML):

<a href="https://oncologytube.com/v/28761?channelName=obr"><img src="https://oncologytubecom.cdn.ypt.me/videos/video_190627213943_af20/video_190627213943_af20.jpg?cache=15669161161682794628">Data on Umbralisib in Relapsed/Refractory Lymphoma</a>

Link (BBCode):

[url=https://oncologytube.com/v/28761?channelName=obr][img]https://oncologytubecom.cdn.ypt.me/videos/video_190627213943_af20/video_190627213943_af20.jpg?cache=15669161161682794628[/img]Data on Umbralisib in Relapsed/Refractory Lymphoma[/url]

Συνδεθείτε τώρα!

Permanent Link

URL Friendly (SEO)

Current Time (SEO)

Κατηγορία:

Lymphoma

Περιγραφή:

Lori A. Leslie, MD, Hematologist-Oncologist, Lymphoma Department, John Theurer Cancer Center, Hackensack Meridian Health explains the results of the umbralisib phase II study involving patients with relapsed/refractory lymphoma.